What You Should Know
The U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy, Jr., has unveiled "Operation Trialblazer," a sweeping, department-wide initiative designed to bring clinical research and investment back to the United States.The strategic pivot addresses an alarming competitive gap: China's global share of Phase 1 trials surpassed the U.S. for the first time in 2021, and in 2024, China exceeded the U.S. in total clinical trial registrations with
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
What Senior Leaders Actually Need to Know About Scaling Digital in
Pharma
Digital transformation in pharma usually starts off strong, big vision, budget gets approved, everyone’s aligned, but scaling it is where things get messy. At the leadership level, this really becomes an orchestration problem. It’s like trying to expand a manufacturing plant while everything is still running. You can’t pause production, you can’t mess up compliance, and you definitely can’t create chaos on the floor. Scaling digital works the same way. You’re layering in new systems, new
Read More
Why Validation is Becoming the Proving Ground for AI in Life Sciences
The measurable business impact of AI is lagging way behind the hype. McKinsey found that about 80% of companies now use gen AI in at least one function, yet only about 40% are seeing EBIT impact from it. Of that 40%, most of the measurable impact falls under 5%. Another concerning finding is that nearly half of the IT organizations surveyed plan to increase their investment in gen AI, yet investment is actually decreasing in the foundations needed to scale gen AI, like secure infrastructure,
Read More
Leveraging Real-World Data for Proactive Protocol Design
Clinical trials have grown more complex than ever before. Protocols are becoming more specialized, endpoints more refined, and eligibility criteria narrower and more precise. At the same time, development programs are expected to move faster and operate with greater efficiency. Despite this dual pressure, feasibility projections often rely on high-level estimates or investigator recall rather than validated assessments of patients who truly meet protocol criteria in a real-world clinical
Read More
ConcertAI Expands CancerLinQ Suite with AI-Driven Trial Matching
What You Should Know
Healthcare intelligence leader ConcertAI has unveiled major AI-driven enhancements to its CancerLinQ Suite at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.Powered by Cara, ConcertAI’s proprietary agentic AI platform, the suite automatically parses structured and unstructured data on a weekly basis across a massive footprint of 13 million patient records.The upgraded TriaLinQ module automates patient screening for complex biomarkers and lines of
Read More
Cypher AI Secures $2M to Scale AI-Native Infrastructure for Life Science R&D
What You Should Know
Life science infrastructure startup Cypher AI has emerged from stealth, announcing a $2M seed funding round led by MaC Venture Capital.The financing includes strategic participation from Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures.Founded in 2025 by former scientist and engineer Yaoyu Yang, PhD, the platform replaces fragmented spreadsheets, disconnected Electronic Lab Notebooks (ELNs), and legacy Laboratory Information Management
Read More
b.well Connected Health Partners with myTomorrows to Launch AI-Driven Clinical Trial Matching Stack
What You Should Know
Consumer health data platform b.well Connected Health has announced a strategic partnership with global health tech leader myTomorrows to automate and accelerate how patients are matched and enrolled into clinical trials.The collaboration combines b.well’s extensive, FHIR-based data network—which integrates longitudinal records from nearly 2.4 million providers, 330 health plans, and multiple state health information exchanges (HIEs)—with myTomorrows’ AI-powered clinical
Read More
Century Health Raises $5M for CHARM AI Platform to Accelerate Life Sciences Research
What You Should Know
Century Health has closed an oversubscribed $5M seed financing round led by Origin Ventures, bringing its total funding to an industry-accelerated position.The platform's proprietary Century Health Abstraction & Retrieval Model (CHARM) automates the curation of unstructured EHR data (notes, reports, and documentation), achieving a 97% accuracy rate validated against clinical expert judgment.Century Health expanded its specialty provider data network 60x over the past
Read More
Parexel Launches ParexelAI Suite of Human-Led AI Services for Clinical Trials
What You Should Know
Parexel has introduced ParexelAI™, a proprietary suite of human-led AI services designed to accelerate clinical development operations.Quantified Efficiencies: The suite is already delivering a 50% reduction in site selection timelines, a 30% reduction in medical writing for Clinical Study Reports, and a 20% reduction in safety literature screening.Regulatory Acceleration: Through a strategic partnership with Weave Bio, Parexel is reducing Investigational New Drug (IND)
Read More
Roche Acquires PathAI to Automate Cancer Diagnostics in $1B Deal
What You Should Know
Global healthcare leader Roche has entered into a definitive merger agreement to acquire US-based digital pathology pioneer PathAI for an upfront purchase price of $750M, with up to $300M in additional milestone payments.The acquisition marks the culmination of a deep strategic partnership first established between the two companies in 2021 and expanded in 2024 to co-develop AI-enabled companion diagnostic algorithms.PathAI’s flagship AISight Image Management System (IMS)
Read More
